BAGSVAERD, DENMARK--(Marketwired - Apr 30, 2013) -
Company announcement No 31 2013:
http://hugin.info/2013/R/1697868/559662.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1697868]
Further information: Media: Anne Margrethe Hauge Tel: +45 4442 3450 Email Contact Ken Inchausti (US) Tel: +1 609 514 8316 Email Contact Investors: Kasper Roseeuw Poulsen Tel: +45 4442 4303 Email Contact Frank Daniel Mersebach Tel: +45 4442 0604 Email Contact Lars Borup Jacobsen Tel: +45 3075 3479 Email Contact Jannick Lindegaard (US) Tel: +1 609 786 4575 Email Contact
